Hypersusceptibility to Azole Antifungals in a Clinical Isolate of Candida glabrata with Reduced Aerobic Growth
- 1 July 2009
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (7) , 3034-3041
Abstract
Petite mutations have been described in Saccharomyces cerevisiae and pathogenic yeasts. However, previous studies of the phenotypic traits of these petite mutants reported that they express azole resistance. We describe a clinical isolate of Candida glabrata with a striking association between increased susceptibility to azoles and respiratory deficiency. This isolate was obtained from a urine sample together with a respiration-competent C. glabrata isolate which exhibited azole resistance. The respiratory status of the two isolates was confirmed by cultivation on glycerol-containing agar and oxygraphy. Flow cytometry revealed the normal incorporation of rhodamine 123, and mitochondrial sections with typical cristae were seen by transmission electron microscopy for both isolates. Together, these results suggested a nuclear origin for the reduced respiratory capacity of the hypersusceptible isolate. The sterol contents of these isolates were similar to the sterol content of a reference strain. Sequencing of the ERG11 and PDR1 genes revealed that the sequences were identical in the two isolates, demonstrating their close relatedness. In addition to silent mutations, they carried a nonsense mutation in PDR1 that led to the truncation of transcription factor Pdr1p. They also overexpressed both PDR1 and one of its targets, CDR1 , providing a possible explanation for the azole resistance of the respiration-competent isolate. In conclusion, in addition to azole resistance, which is a common feature of C. glabrata mitochondrial petite mutants, the mutation of a nuclear gene affecting aerobic growth may lead to azole hypersusceptibility; however, the mechanisms underlying this phenotype remain to be determined.Keywords
This publication has 26 references indexed in Scilit:
- Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance VirulencePLOS Pathogens, 2009
- Therapeutic Drug Monitoring of VoriconazoleTherapeutic Drug Monitoring, 2008
- Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans IsolatesEukaryotic Cell, 2007
- ACandida albicansPetite Mutant Strain with Uncoupled Oxidative Phosphorylation OverexpressesMDR1and Has Diminished Susceptibility to Fluconazole and VoriconazoleAntimicrobial Agents and Chemotherapy, 2007
- Reduced Susceptibility to Polyenes Associated with a Missense Mutation in the ERG6 Gene in a Clinical Isolate of Candida glabrata with Pseudohyphal GrowthAntimicrobial Agents and Chemotherapy, 2007
- Candida glabrata PDR1 , a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite MutantsAntimicrobial Agents and Chemotherapy, 2006
- Mechanisms of Azole Resistance in Petite Mutants of Candida glabrataAntimicrobial Agents and Chemotherapy, 2004
- Systematic screen for human disease genes in yeastNature Genetics, 2002
- Genetic Basis of Mitochondrial Function and Morphology inSaccharomyces cerevisiaeMolecular Biology of the Cell, 2002
- The Mitochondrial Genotype Can Influence Nuclear Gene Expression in YeastScience, 1987